U.S. Senator Angus King Receives 5-Star Rating From Prescription Justice
We are pleased to announce that U.S. Senator Angus King (I-ME) has received the Prescription Justice 5-star rating based on his full support of the organization’s Policy Platform to lower drug prices here and expand access to safe and affordable medication from other countries. Senator King’s 5-star rating reflects his unwavering support of commonsense policy solutions to end the prescription drug affordability crisis. Members of Congress get one star for their positions on the following:
1. Recognizes that the United States is suffering from a crisis of high drug prices?
2. Ending the ban that prevents Medicare from negotiating lower drug prices with pharmaceutical companies;
3. Making reverse payment arrangements between brand and generic companies, also known as “pay-for-delay” illegal;
4. Legalizing the importation of lower-cost medication from Canada and other countries with similarly strict pharmaceutical regulations; and
5. Using reasonable, commonsense, and compassionate enforcement discretion to permit individuals to import small quantities of affordable medication to fill prescriptions.
We applaud Senator King for his courage to stand up to the pharmaceutical industry and for his ardent leadership in Congress in making prescription drugs more affordable for Americans. Most recently, Senator King has co-sponsored important legislation, which closely align with the policy priorities of Prescription Justice, including:
The Medicare Prescription Drug Price Negotiation Act, which would allow Medicare to negotiate drug prices.
The Affordable and Safe Prescription Drug Importation Act, to allow for the importation of affordable and safe drugs by wholesale distributors, pharmacies, and individuals.
The Safe and Affordable Drugs from Canada Act of 2017, bipartisan legislation that would allow individuals to safely import prescription drugs from Canada.
Empowering Medicare Seniors to Negotiate Drug Prices Act of 2017, to allow the Centers for Medicare & Medicaid Services to negotiate drug prices under the Medicare prescription drug benefit.
Tags
Archives
- All
- January 2024
- April 2023
- October 2022
- September 2022
- August 2022
- June 2022
- April 2022
- January 2022
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- October 2020
- September 2020
- August 2020
- July 2020
- March 2020
- February 2020
- December 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- April 2019
- February 2019
- December 2018
- September 2018
- June 2018
- May 2018
- April 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- November 2015